Antimetastatic activity of lymphokine-activated killer cells to rat fibrosarcoma (WBT-2M) and rat mammary carcinoma (SST-2).
D000818:Animals; D000920:Antibody-Dependent Cell Cytotoxicity; D005260:Female; D005354:Fibrosarcoma / Q000276:immunology / Q000556:secondary / Q000628:therapy*; D007116:Immunization, Passive; D007376:Interleukin-2 / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology / Q000637:transplantation*; D008175:Lung Neoplasms / Q000276:immunology / Q000556:secondary / Q000628:therapy*; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000276:immunology / Q000628:therapy*; D051381:Rats; D011918:Rats, Inbred SHR
D007376:Interleukin-2